Eric J. Ende - Jan 1, 2022 Form 3 Insider Report for NeuBase Therapeutics, Inc. (NBSE)

Role
Director
Signature
/s/ Dietrich Stephan, as attorney-in-fact for Eric Ende
Stock symbol
NBSE
Transactions as of
Jan 1, 2022
Transactions value $
$0
Form type
3
Date filed
1/5/2022, 03:04 PM
Previous filing
Nov 2, 2021
Next filing
May 31, 2022

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney